Karissa Mizner Atkins
Pharmacist · Savannah, GA
Karissa Mizner Atkins is a pharmacist with a practice address in Savannah, Georgia, and NPI 1659708048, issued on Oct 1, 2013. Check the license (Georgia RPH027446, as entered in NPPES) with the Georgia board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Karissa Mizner Atkins
- Primary taxonomy
- Pharmacist 183500000X
- License number
- RPH027446 GA
Self-reported in NPPES; status is on the state search - Practice location
- 2 Saint Ives Dr, Savannah, GA 31419
- Phone
- (662) 701-1327
- Enumerated
- Oct 1, 2013
- Record last updated
- Dec 22, 2022
- Entity
- Type 1 · individual
Verify Karissa Mizner Atkins in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich Georgia board licenses this profession
Search for license RPH027446Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Most of these Medicare Part D claims are vaccines, 95% of the cost of the top drugs
94 Medicare Part D claims for 84 beneficiaries, against an average of 119 among the 28,524 providers of this specialty who prescribed in Part D. Brand-name drugs were 99% of claims.
Most prescribed
Pharmacies often give vaccines under a standing order that names one clinician, and CMS counts every such claim under that clinician's NPI. These claims are therefore not a measure of this clinician's own prescribing.
- Shingrix40 claims
- Arexvy37 claims
- Boostrix Tdap16 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
249 pharmacist records list a practice address in Savannah
They are 249 of the 5,692 NPPES records with a practice address in Savannah, and 8,291 pharmacist records in Georgia.
All 249 in Savannah → All 8,291 in Georgia → Every provider in Savannah →
Other pharmacist records in Georgia
- Robert Aaron, RPHCornelia, GA1720411408
- Helen Abasute, PHARM.DAtlanta, GA1053703710
- Betelhem AbatnehStockbridge, GA1215711957
- Hoda AbbasiMarietta, GA1851062848
- Lauren Abbott, PHARMDOmega, GA1164058566
- Alharith Abdel-RazzaqAcworth, GA1710823133
- Mohammed Abdelsaid, RPHRichmond Hill, GA1366016214
- Huda AbdiTucker, GA1174036032
- Kareema Abdul-Barr, RPHMarietta, GA1124376561
- Fozi AbdulahiMartinez, GA1972886752
Common questions
What is Karissa Mizner Atkins's NPI number?
Karissa Mizner Atkins's National Provider Identifier (NPI) is 1659708048, issued on Oct 1, 2013. An NPI identifies a provider in billing; it is not a license.
Where is Karissa Mizner Atkins located?
The NPPES record lists a practice address at 2 Saint Ives Dr, Savannah, GA, 31419. Phone: (662) 701-1327. Providers update this record themselves, so call before visiting.
How can I verify Karissa Mizner Atkins's license?
NPPES lists Georgia license number RPH027446, as entered by the provider. Search the Georgia board that licenses this profession; the NPPES record confirms identity only.
How much does Karissa Mizner Atkins prescribe under Medicare Part D?
In 2024, Karissa Mizner Atkins had 94 Medicare Part D claims for 84 beneficiaries; the average among pharmacist prescribers was 119. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.